High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 10 Best Debt-Free S&P 500 Stocks to Buy Now. On May 27, 2026, Goldman Sachs lowered the firm’s price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $558 from $621 and maintained a Buy rating on the shares. Goldman Sachs said MedTech has gone through one of its […]
In late May 2026, Intuitive Surgical announced that Global Senior Vice President of its endoluminal business Taylor Patton will become Chief Commercial and Marketing Officer from July 1, while Henry Charlton transitions to Senior Vice President of Global Business Operations. This leadership shift pairs Patton’s experience across the da Vinci, Ion, and digital platforms with Charlton’s operational focus, aiming to strengthen Intuitive’s ability to scale robotic-assisted and minimally invasive...
Intuitive Surgical's stock is in the middle of a deep drawdown, which is actually pretty common for this stock.
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
Jensen Huang keeps quoting a $40 trillion humanoid robot TAM, and the market is rewarding every concept video and 2030 roadmap that mentions the word robot. I have been studying physical AI deployments for the better part of two years, and here is what I keep coming back to: the names that survive the inevitable ... 5 Stocks With Real Revenue From Physical AI Today (Not 2030 Promises)
Boston Scientific (BSX) previously commanded a premium valuation based on its transition toward a high-margin cardiovascular powerhouse, driven by its FARAPULSE Pulsed Field Ablation (PFA) system and WATCHMAN cardiac implant. In Q1 2026, the cardiovascular segment posted a strong 13.5% reported growth. However, intense competition from Medtronic (MDT) and Johnson & Johnson (JNJ) has challenged this hyper-growth thesis. Johnson & Johnson's Varipulse system integrates directly into the dominant CA
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best medical technology stocks to buy right now. On May 21, Intuitive Surgical, Inc. (NASDAQ:ISRG) announced a major round of updates to its da Vinci 5 robotic surgical system, including extended instrument use capabilities. The company said more than 100 improvements will roll out to US customers […]
Intuitive Surgical (ISRG) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ISRG is widening its robotic surgery lead with faster growth, rising procedures and a recurring revenue model as Medtronic builds Hugo.
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best medical stocks to invest in according to billionaires. Intuitive Surgical, Inc. (NASDAQ:ISRG) announced on May 21 several recent and upcoming innovations, which included enhancements across da Vinci 5 and its supporting ecosystem, advancements designed to enhance product and instrument security and reliability, and extended‑use Force Feedback instruments. Management stated […]
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best robotic surgery stocks to buy. BofA cut the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $520 from $650 on May 18, reiterating a Buy rating on the shares. The firm told investors that after having hosted 34 medtech companies the week before in Las Vegas, it […]
ISRG's Ion platform saw 39% procedure growth in Q1, with new clinical data strengthening its role in lung cancer diagnosis.
Over the last six months, Intuitive Surgical’s shares have sunk to $442.32, producing a disappointing 19.9% loss - a stark contrast to the S&P 500’s 13.2% gain. This might have investors contemplating their next move.
Intuitive Surgical (NasdaqGS:ISRG) has outlined more than 100 new features coming to its da Vinci 5 surgical platform. Key additions include extended-use Force Feedback instruments, security and reliability upgrades, and telepresence tools for remote collaboration. The company expects these updates to broaden the platform’s capabilities in minimally invasive robotic surgery and support surgeon autonomy. For investors watching NasdaqGS:ISRG at a share price of $439.8, this product update...
While Intuitive Surgical has notably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 7.8% has lagged the S&P 500’s 13.2% climb.
Intuitive Surgical’s da Vinci 5 surgical platform, which began shipping in earnest on April 1, 2026, runs on 10,000 times the computing power of the da Vinci Xi and was co-engineered with NVIDIA’s Isaac platform. That is a working hospital robot, on the floor, today, that needed an AI compute stack nobody had five years ... Quantum Computing and Robotics Are Arriving Faster Than Most Investors Realize and After Years of Covering This Space These 3 ETFs Stand Out
It'd be a mistake to overlook these stocks, despite their recent challenges.
Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ISRG's SP platform sees Q1 2026 procedures jump 68%, with new approvals and tools raising a key question: TAM expansion or procedure shift?
Globus Medical, Inc. (NYSE:GMED) was among the stocks Jim Cramer looked at as he explained the need for a tame bond market for the stock market to go higher. A caller asked for Cramer’s thoughts on the company, and he remarked: Okay, this group in particular, the medical device group, is hated in this market. […]
Boston Scientific (BSX) stock declined 47% over the last 12 months to trade near $57. Despite total revenues growing 17.4% to $20.6 billion and net income margins improving to 17.3%, the P/E multiple contracted by 70%. The selloff was triggered by a Q4 2025 GAAP EPS miss and a significant full-year 2026 organic growth guidance cut. The company's management lowered the target from a 10 to 11% range down to 6.5 to 8.0%, attributing the reset to greater-than-expected market share loss in the Electr
Everyone is still glued to Tesla (NASDAQ:TSLA) because a Q1 earnings beat, the robotaxi pitch, and the Optimus humanoid tease have convinced retail traders the autonomy story finally pays off this year. The Tesla Trade Is Crowded and Priced for a Miracle Tesla carries a P/E of 406 and a free cash flow yield of ... Forget Tesla. The Robotics Company Actually Shipping Revenue Has a $22 Billion Backlog and Nobody Is Talking About It
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Recent performance context for Intuitive Surgical Intuitive Surgical (ISRG) has been under pressure recently, with the stock down about 10% over the past month and about 15% over the past 3 months. This has prompted investors to reassess expectations. See our latest analysis for Intuitive Surgical. Beyond the recent pullback, the stock has also declined about 25% based on the year to date share price return, even though the 3 year and 5 year total shareholder returns remain positive. If you...
Surgical robotics is quietly becoming an artificial intelligence story. Every robotic procedure generates structured video, kinematic, and outcomes data that platforms feed back into surgeon training, intraoperative guidance, and predictive analytics. That flywheel is the moat. The three companies owning the installed bases to build it are Intuitive Surgical (NASDAQ: ISRG), Medtronic (NYSE: MDT), and ... Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays
Intuitive Surgical is in its own bear market, which has historically been a good time for aggressive growth investors to buy.
ISRG's da Vinci 5 is driving stronger utilization and procedure growth, but can higher throughput and after-hours surgeries sustain momentum?
With an upside potential of 35.5%, Intuitive Surgical, Inc. (NASDAQ:ISRG) remains a bullish pick among analysts. The stock, therefore, earns its place on our list of the best agentic AI stocks to buy right now. On April 21, 2026, Intuitive Surgical, Inc. (NASDAQ:ISRG) reported strong first-quarter results, exceeding Wall Street projections in both revenue and […]
Danaher Corporation (NYSE:DHR) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market. Cramer called it a “one-time excellent company,” as he said: For instance, Danaher, another one-time excellent company, has seen the stock just get pulverized after not-so-great quarters, or I […]
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.